Comparative effectiveness and safety of nab-paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cancer in a US community oncology setting

INTRODUCTION: Real-world comparative effectiveness, safety, and supportive care use of nab-paclitaxel plus carboplatin vs gemcitabine plus platinum were analyzed in patients with advanced or metastatic squamous cell non-small cell lung cancer (NSCLC). MATERIALS AND METHODS: Patients who received ≥ 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Mudad, Raja, Patel, Manish B, Margunato-Debay, Sandra, Garofalo, David, Lal, Lincy S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656340/
https://www.ncbi.nlm.nih.gov/pubmed/29089791
http://dx.doi.org/10.2147/LCTT.S139647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656340/
https://www.ncbi.nlm.nih.gov/pubmed/29089791
http://dx.doi.org/10.2147/LCTT.S139647

Ejemplares similares